|
HY-14609-10mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-5mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-50mg
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609-1mL
|
MedChemexpress LLC
|
MPEP (Hydrochloride) [CAS 219911-35-0] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-14609A-250mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-10mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-100mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-5mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-50mg
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14609A-1mL
|
MedChemexpress LLC
|
MPEP [CAS 96206-92-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1821A-10mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1821A-5mg
|
MedChemexpress LLC
|
Myelin Basic Protein (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-140521-100mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140521-50mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140087-100mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140087-25mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140087-50mg
|
MedChemexpress LLC
|
N-(Amino-PEG2)-N-bis(PEG3-azide)
|
|
Cancer-programmed cell death
|
|
|
HY-140867-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140867-250mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140867-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-bis(PEG4-Boc) [CAS 2112731-81-2]
|
|
Cancer-programmed cell death
|
|
|
HY-140562-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-Boc [CAS 2093153-07-0]
|
|
Cancer-programmed cell death
|
|
|
HY-140562-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-Boc [CAS 2093153-07-0]
|
|
Cancer-programmed cell death
|
|
|
HY-140559-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-NHS ester [CAS 2093153-85-4]
|
|
Cancer-programmed cell death
|
|
|
HY-140559-50mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG3-NHS ester [CAS 2093153-85-4]
|
|
Cancer-programmed cell death
|
|
|
HY-140525-100mg
|
MedChemexpress LLC
|
N-(Azido-PEG2)-N-Boc-PEG4-acid [CAS 2093153-82-1]
|
|
Cancer-programmed cell death
|
|
